The aim of this study is to investigate peptides generated from whey proteins hydrolyzed by the non-commercial proteolytic enzyme obtained from Asian pumpkin as the natural sources of DPP-IV, α-glucosidase and ACE inhibitors that can be used as functional food ingredients for the complex management of type 2 diabetes and hypertension. This evidence concerns the gene DPP4 and type 2 diabetes mellitus.